CA3054834C — Ready-to-use bivalirudin compositions
Assigned to Maia Pharmaceuticals Inc · Expires 2025-06-17 · 1y expired
What this patent protects
Ready-to-use liquid bivalirudin compositions, methods of using the ready-to- use bivalirudin compositions, and methods of preparing the ready-to-use liquid bivalirudin compositions are provided herein. The liquid ready-to-use bivalirudin compositions comprise a pharmaceutically a…
USPTO Abstract
Ready-to-use liquid bivalirudin compositions, methods of using the ready-to- use bivalirudin compositions, and methods of preparing the ready-to-use liquid bivalirudin compositions are provided herein. The liquid ready-to-use bivalirudin compositions comprise a pharmaceutically acceptable amount of bivalirudin.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.